PhaseRx, Inc. (PZRX) financial statements (2021 and earlier)

Company profile

Business Address 410 WEST HARRISON STREET
SEATTLE, WA 98119
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:16
Cash and cash equivalents10
Short-term investments5
Other undisclosed cash, cash equivalents, and short-term investments0
Other undisclosed current assets1
Total current assets:16
Noncurrent Assets
Property, plant and equipment0
Total noncurrent assets:0
TOTAL ASSETS:16
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1
Accounts payable1
Accrued liabilities1
Interest and dividends payable0
Debt1
Total current liabilities:2
Noncurrent Liabilities
Long-term debt and lease obligation5
Long-term debt, excluding current maturities5
Total noncurrent liabilities:5
Total liabilities:7
Stockholders' equity
Stockholders' equity attributable to parent9
Common stock0
Additional paid in capital79
Accumulated other comprehensive income0
Accumulated deficit(69)
Total stockholders' equity:9
TOTAL LIABILITIES AND EQUITY:16

Income statement (P&L) ($ in millions)

12/31/2016
Operating expenses(18)
Operating loss:(18)
Nonoperating expense(2)
Interest and debt expense(2)
Net loss:(22)
Other undisclosed net income attributable to parent2
Net loss available to common stockholders, diluted:(20)

Comprehensive Income ($ in millions)

12/31/2016
Net loss:(22)
Comprehensive loss:(22)
Other undisclosed comprehensive income, net of tax, attributable to parent2
Comprehensive loss, net of tax, attributable to parent:(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: